The Prognostic Value of p16 Hypermethylation in Cancer: A Meta-Analysis.
The prognostic value of p16 promoter hypermethylation in cancers has been evaluated for several years while the results remain controversial. We thus performed a systematic review and meta-analysis of studies assessing the impact of p16 methylation on overall survival (OS) and disease-free survival...
Main Authors: | Xiang-Bin Xing, Wei-Bin Cai, Liang Luo, Long-Shan Liu, Hui-Juan Shi, Min-Hu Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3689792?pdf=render |
Similar Items
-
Hypermethylation of LATS2 Promoter and Its Prognostic Value in IDH-Mutated Low-Grade Gliomas
by: Yuan Gu, et al.
Published: (2020-10-01) -
Hypermethylation of N-Acetyltransferase 1 Is a Prognostic Biomarker in Colon Adenocarcinoma
by: Cheng Shi, et al.
Published: (2019-11-01) -
The hypermethylation of p16 gene exon 1 and exon 2: potential biomarkers for colorectal cancer and are associated with cancer pathological staging
by: Xiaoxia Ye, et al.
Published: (2018-10-01) -
Clinicopathological and prognostic significance of CDH1 hypermethylation in hepatocellular carcinoma: a meta-analysis
by: Wu X, et al.
Published: (2019-01-01) -
Cigarette smoking and p16INK4α gene promoter hypermethylation in non-small cell lung carcinoma patients: a meta-analysis.
by: Bo Zhang, et al.
Published: (2011-01-01)